1. Home
  2. Labeler Index
  3. Long Grove Pharmaceuticals, Llc
  4. 81298-7050
  5. NDC Package Code: 81298-7050-3 Edaravone

NDC Package 81298-7050-3 Edaravone

Solution Intravenous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
81298-7050-3
Package Description:
2 BAG in 1 CARTON / 100 mL in 1 BAG (81298-7050-1)
Product Code:
81298-7050
Proprietary Name:
Edaravone
Non-Proprietary Name:
Edaravone
Substance Name:
Edaravone
Usage Information:
Edaravone is used to treat a certain type of nerve disease called amyotrophic lateral sclerosis (ALS, also commonly called Lou Gehrig's disease). It helps to slow down the worsening of this disease. However, it is not a cure for ALS, and it does not reverse nerve damage or muscle weakness.
11-Digit NDC Billing Format:
81298705003
NDC to RxNorm Crosswalk:
Product Type:
Human Prescription Drug
Labeler Name:
Long Grove Pharmaceuticals, Llc
Dosage Form:
Solution - A clear, homogeneous liquid1 dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents.
Administration Route(s):
Intravenous - Administration within or into a vein or veins.
Active Ingredient(s):
EDARAVONE 30 mg/100mL
Sample Package:
No
FDA Application Number:
ANDA218354
Marketing Category:
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date:
05-13-2024
Listing Expiration Date:
12-31-2025
Exclude Flag:
N
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 81298-7050-3?

The NDC Packaged Code 81298-7050-3 is assigned to a package of 2 bag in 1 carton / 100 ml in 1 bag (81298-7050-1) of Edaravone, a human prescription drug labeled by Long Grove Pharmaceuticals, Llc. The product's dosage form is solution and is administered via intravenous form.

Is NDC 81298-7050 included in the NDC Directory?

Yes, Edaravone with product code 81298-7050 is active and included in the NDC Directory. The product was first marketed by Long Grove Pharmaceuticals, Llc on May 13, 2024 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 81298-7050-3?

The 11-digit format is 81298705003. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-4-181298-7050-35-4-281298-7050-03